Callaghan Innovation appoints CEO all the way from Alaska

Callaghan Innovation has today announced the appointment of Dr Mary Quin as the inaugural CEO of the organisation.

With over 20 years’ experience working in senior executive roles in NASDAQ-listed companies such as Xerox and Eastman Kodak Company, Dr Quin will relocate from Anchorage, Alaska to Wellington.

“With her knowledge of industry and her business acumen, we believe that she can drive substantial commercialisation opportunities for Callaghan Innovation and for New Zealand companies,” says Sue Suckling, chair, Callaghan Innovation.

“Her international experience will also be invaluable as a key goal of the organisation is to grow and scale New Zealand’s innovation and sell it to world markets."

Palmerston North-born, Dr Quin willl begin her new role on May 3, with her main responsibilities including ensuring the organisation accelerates the commercialisation of innovation of New Zealand firms in order to strengthen export capability and grow New Zealand’s economy.

“The creation of Callaghan Innovation has launched exciting new possibilities for generating commercial value from Kiwi ingenuity, science, technology and ideas," Dr Quin says.

"I am delighted to be joining not only the talented research, engineering and investment teams already at Callaghan Innovation but also New Zealand’s network of businesses, investors, and educational, research and government institutions, as we tackle our challenging new mission together."